Aquatic Animals
Veterinary (Pet) Therapeutic Antibody Research & Development
Workflow of Pet Therapeutic Antibody R&D
Our pet therapeutic antibody research and development workflow is a structured, multi-step process designed for clarity, efficiency, and successful outcomes. It is suitable for visualization as a flowchart, detailing each stage of the journey from initial concept to final deliverables.
1. Required Starting Materials
Target Antigen Information: Detailed information about the specific protein or target molecule you aim to modulate, including sequence, source species, and any known functional characteristics.
Target Animal Species: Clear identification of the specific pet species (e.g., canine, feline) for which the therapeutic antibody is intended.
Project Goals and Specific Requirements: A clear outline of the desired therapeutic effect, target binding characteristics (e.g., blocking, activating), and any specific format requirements (e.g., scFv, Fab, IgG).
2. Antigen Preparation and Validation
We begin by preparing high-quality, validated antigen relevant to your target. This may involve recombinant protein expression, peptide synthesis, or other methods, ensuring the antigen is suitable for antibody discovery platforms. The high-purity and functional antigen are ready for screening and animal immunization.
Pet Therapeutic Antibody Target Discovery
Veterinary Antigen Services
3. Species-Specific Monoclonal Antibody Discovery
Utilizing advanced platforms such as phage display, single-B cell sorting, or hybridoma technology, we screen vast antibody repertoires to identify lead candidates that bind specifically and with high affinity to your target antigen in the target pet species. Our services are able to identify of diverse antibody candidates with desired binding properties.
Pet Therapeutic Antibody Discovery
Phage Display Antibody Discovery
Single-B Cell Antibody Discovery
Hybridoma Antibody Discovery
Antibody Characterization
4. Antibody Engineering and Optimization
Lead antibody candidates undergo engineering to improve their therapeutic properties. This can include species-specific adaptation (caninization, felinization), affinity maturation, format conversion (e.g., scFv to full IgG), or Fc engineering to modulate effector functions and half-life. We will deliver optimized antibody sequences with enhanced specificity, affinity, and developability characteristics.
Antibody Engineering
5. Validation and Evaluation
The purified antibodies undergo rigorous in vitro and potentially in vivo evaluation. In vitro tests assess binding characteristics, specificity (including cross-reactivity), and functional activity. In vivo studies can assess pharmacokinetics (PK), pharmacodynamics (PD), efficacy, and safety in relevant animal models or the target species, depending on the project stage and requirements. The outcome is a comprehensive dataset characterizing the antibody's properties and potential.Pet Therapeutic Antibody Evaluation
6. Small-Scale Antibody Development
For Pet Therapeutic Antibody Development, comprehensive services starting with crucial developability evaluation and optimization. This is followed by expert cell line and cell culture process development. We manage efficient antibody purification and subsequent stability and formulation development. Our non-GMP production capabilities deliver high-quality material necessary to advance your antibody candidates through preclinical studies and toward clinical evaluation in pets.
Pet Therapeutic Antibody Development
7.Final Deliverables
Upon project completion, you will receive:
Comprehensive Report: A detailed report summarizing all experimental procedures, results, data analysis, and conclusions from each stage of the project.
Sequence Information: Full amino acid and nucleotide sequences of the selected lead antibody candidates.
Constructs/Materials: Expression constructs or purified antibody material for the lead candidates, depending on the project scope.
8.Estimated Timeframe
The typical timeframe for pet therapeutic antibody research and development projects is depending on the complexity of the target, the discovery platform utilized, and the scope of engineering and evaluation required.